scholarly journals Association of Elevated Serum Ferritin Levels and the Risk of Gestational Diabetes Mellitus in Pregnant Women: The Camden Study

Diabetes Care ◽  
2006 ◽  
Vol 29 (5) ◽  
pp. 1077-1082 ◽  
Author(s):  
X. Chen ◽  
T. O. Scholl ◽  
T. P. Stein
Open Medicine ◽  
2021 ◽  
Vol 17 (1) ◽  
pp. 70-86
Author(s):  
Fatemeh Alsadat Rahnemaei ◽  
Reza Pakzad ◽  
Azam Amirian ◽  
Iraj Pakzad ◽  
Fatemeh Abdi

Abstract Gestational diabetes mellitus (GDM) can have adverse effects on pregnancy. GDM is associated with changes in the lipid profile of pregnant women. Finding out the early ways to diagnose GDM can prevent the adverse outcomes. This meta-analysis study aimed to determine the effect of GDM on lipid profile. PubMed, ProQuest, Web of Science, Scopus, Science Direct, Google Scholar, and ClinicalTrial were systematically searched for published articles relating to GDM until 2021 according to PRISMA guidelines. Newcastle Ottawa scale was used to assess the quality of the studies. Thirty-three studies with a sample size of 23,792 met the criteria for entering the meta-analysis. Pooled standardized mean difference (SMD) for total cholesterol (TC) and triglyceride (TG) was 0.23 mg/dL (95% CI: 0.11–0.34) and 1.14 mg/dL (95% CI: 0.91–1.38), respectively. The mean of TC and TG in people with GDM was higher than that in normal pregnant women. A similar pattern was observed for the very low-density lipoprotein (VLDL) and TG/high-density lipoprotein (HDL) ratio, with pooled SMD of 0.99 mg (95% CI: 0.71–1.27) and 0.65 mg (95% CI: 0.36–0.94), respectively. Pooled SMD for HDL was −0.35 mg/dL (95% CI: −0.54 to −0.16), women with GDM had a mean HDL lower than normal pregnant women. Although pooled SMD was higher for low-density lipoprotein (LDL) in the GDM group, this difference was not significant (0.14 [95% CI: −0.04 to 0.32]). Of all the lipid profiles, the largest difference between the GDM and control groups was observed in TG (SMD: 1.14). Elevated serum TG had the strongest effect on GDM. Higher levels of TC, LDL, VLDL, and TG/HDL ratio, and lower level of HDL were exhibited in GDM group. So, these markers can be considered as a reliable marker in the diagnosis of GDM.


2020 ◽  
Author(s):  
Yao Liu ◽  
Yan Li ◽  
Hengying Chen ◽  
Ruifang Sun ◽  
Yuanhuan Wei ◽  
...  

Abstract BackgroudBile acid metabolism is reported to be closely involved in glycolipid metabolism. We investigated the association of the total bile acid (TBA) levels at the second trimester with the risk of gestational diabetes mellitus (GDM) and adverse perinatal outcomes.MethodsWe performed a retrospective cohort study in 2773 Chinese pregnant women. Serum TBA level was measured by a biochemistry automatic analyzer. Logistic regression models with or without restricted cubic splines were performed.Results652 of 2773 pregnant women developed GDM. Women with GDM had higher serum TBA levels at the second trimester than that of healthy women (P < 0.001). Elevated serum TBA levels at the second trimester were associated with an increased risk of GDM in a dose-response manner. After the adjustment of age, BMI, smoking and drinking status, education background, lipid profiles, blood pressure, liver function, uric acid, bilirubin, urea nitrogen and creatinine, the odds ratios (ORs) of GDM for the highest (vs. the lowest) quartile were 1.83 (95% CI 1.10–3.38) in women. The inclusion of TBA levels at the second trimester in the model increased the area under the curve from 0.68 to 0.72 (95% CI: 0.68–0.76) (P < 0.05). Additionally, a higher serum TBA level was associated with higher odds of preterm birth (the highest quartile vs. the lowest quartile, AOR 1.91, 95% CI 1.26–2.98, P-trend = 0.017) and preeclampsia (the highest quartile vs. the lowest quartile, AOR 2.07, 95% CI 1.19–3.63, P-trend = 0.002). Furthermore, the U-shaped relationship was observed between TBA levels and the risk of premature rupture of membranes, with the lowest risk in the TBA concentration of 3.14 µmol/L.ConclusionWomen with higher fasting serum TBA levels at the second trimester have higher risk for development of GDM, preterm birth and preeclampsia.


2018 ◽  
Author(s):  
George Simeakis ◽  
Evangelia Vogiatzi ◽  
Panagiota Konstantakou ◽  
Evangelia Zapanti ◽  
Katerina Saltiki ◽  
...  

Diabetes ◽  
2019 ◽  
Vol 68 (Supplement 1) ◽  
pp. 86-LB
Author(s):  
TIANGE SUN ◽  
FANHUA MENG ◽  
RUI ZHANG ◽  
ZHIYAN YU ◽  
SHUFEI ZANG ◽  
...  

2020 ◽  
Vol 16 (8) ◽  
pp. 895-899 ◽  
Author(s):  
Shahin Safian ◽  
Farzaneh Esna-Ashari ◽  
Shiva Borzouei

Aims: Investigation thyroid dysfunction and autoimmunity in pregnant women with gestational diabetes mellitus. Background: This article was written to evaluate the thyroid function and anti-thyroid peroxidase (anti- TPO) antibodies in pregnant women with gestational diabetes mellitus (GDM). Method: A total of 252 women with GDM and 252 healthy pregnant women were enrolled. Thyroid tests, including TSH, FreeT3, Free T4, and anti-TPO were performed for all women at 24–28 weeks of gestation. Data analysis was then carried out using SPSS ver. 22. Result: There was a significant difference between the experimental group (38.4%) and the control group (14.06%) in terms of the prevalence of subclinical hypothyroidism (p= 0.016). The frequency of anti-TPO was higher in the experimental group than the control group and positive anti-TPO was observed in 18.6% of women with GDM and 10.3% of healthy pregnant women (P= 0.008). Conclusion: Thyroid disorders are observed in pregnant women with GDM more frequently than healthy individuals and it may be thus reasonable to perform thyroid tests routinely.


Placenta ◽  
2019 ◽  
Vol 83 ◽  
pp. e36
Author(s):  
Thiago PB. De Luccia ◽  
Erika Ono ◽  
Karen PT. Pendeloski ◽  
Eloiza LL. Tanabe ◽  
Ana Lúcia M Silva ◽  
...  

Author(s):  
Nasloon Ali ◽  
Aysha S. Aldhaheri ◽  
Hessa H. Alneyadi ◽  
Maha H. Alazeezi ◽  
Sara S. Al Dhaheri ◽  
...  

Gestational diabetes mellitus (GDM) increases the risk of adverse pregnancy outcomes in any pregnancy and recurrence rates are high in future pregnancies. This study aims to investigate the effect of self-reported history of previous GDM on behaviors in a future pregnancy. This is an interim cross-sectional analysis of the pregnant women who participated in the Mutaba’ah Study between May 2017 and March 2020 in the United Arab Emirates. Participants completed a baseline self-administered questionnaire on sociodemographic and pregnancy-related information about the current pregnancy and previous pregnancies. Regression models assessed the relationships between self-reported history of GDM and pre-pregnancy and pregnancy behaviors in the current pregnancy. Out of 5738 pregnant parous women included in this analysis, nearly 30% (n = 1684) reported a history of GDM in a previous pregnancy. Women with a history of previous GDM were less likely to plan their current pregnancies (adjusted odds ratio (aOR): 0.84, 95% confidence interval (CI) 0.74–0.96) and more likely to be worried about childbirth (aOR: 1.18, 95% CI 1.03–1.36). They had shorter interpregnancy intervals between their previous child and current pregnancy (aOR: 0.88, 95% CI 0.82–0.94, per SD increase). There were no significant differences between women with and without a history of GDM in supplement use, sedentary behavior, or physical activity before and during this current pregnancy. Nearly a third of parous pregnant women in this population had a history of GDM in a previous pregnancy. Pregnant women with a previous history of GDM were similar to their counterparts with no history of GDM in the adopted pre-pregnancy and prenatal health behaviors. More intensive and long-term lifestyle counseling, possibly supported by e-health and social media materials, might be required to empower pregnant women with a history of GDM. This may assist in adopting and maintaining healthy prenatal behaviors early during the pregnancy or the preconception phase to minimize the risk of GDM recurrence and the consequential adverse maternal and infant health outcomes.


Sign in / Sign up

Export Citation Format

Share Document